STAT Plus: This biotech went public during the stock market’s worst week since 2008
ADOBE
Philadelphia-based gene therapy company Passage Bio launched its initial public offering in the middle of the market's response to the coronavirus.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario